Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Phillips, A, Walker, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2004

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
ανά: Nicola Gianotti, κ.ά.
Έκδοση: (2017-01-01)

Timeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patients.
ανά: Mathieu Bastard, κ.ά.
Έκδοση: (2012-01-01)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
ανά: Fidler, S, κ.ά.
Έκδοση: (2002)

HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia
ανά: Awachana Jiamsakul, κ.ά.
Έκδοση: (2014-01-01)

Drug monitoring of antiretroviral drugs in children with perinatal HIV infection
ανά: A. Yu. Sambyalova, κ.ά.
Έκδοση: (2024-07-01)

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
ανά: Ledergerber, B, κ.ά.
Έκδοση: (2004)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
ανά: Kekitiinwa, A, κ.ά.
Έκδοση: (2017)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
ανά: Prendergast, A, κ.ά.
Έκδοση: (2008)

HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium
ανά: Georgette D. Kanmogne
Έκδοση: (2024-04-01)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
ανά: Pontiano Kaleebu, κ.ά.
Έκδοση: (2015-01-01)

Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection
ανά: Annalisa Mondi, κ.ά.
Έκδοση: (2022-03-01)

Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia
ανά: Tee, K.K., κ.ά.
Έκδοση: (2006)

HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
ανά: Tsai HC, κ.ά.
Έκδοση: (2018-08-01)

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China.
ανά: Zhongbao Zuo, κ.ά.
Έκδοση: (2016-01-01)

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
ανά: Holberg-Petersen Mona, κ.ά.
Έκδοση: (2009-07-01)

Evaluating a minipool strategy to screen for virologic failure and antiretroviral drug resistance
ανά: H.M. Newman, κ.ά.
Έκδοση: (2014-04-01)

Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
ανά: Paris, D, κ.ά.
Έκδοση: (1999)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
ανά: Szubert, A, κ.ά.
Έκδοση: (2017)

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
ανά: Ahoua Laurence, κ.ά.
Έκδοση: (2009-06-01)

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
ανά: Julie Kadima, κ.ά.
Έκδοση: (2018-01-01)

Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment.
ανά: Bhavna H Chohan, κ.ά.
Έκδοση: (2021-01-01)

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
ανά: Annelot F Schoffelen, κ.ά.
Έκδοση: (2013-01-01)

High rates of virological failure and drug resistance in perinatally HIV‐1‐infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo
ανά: Mounerou Salou, κ.ά.
Έκδοση: (2016-01-01)

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia
ανά: Olivier Segeral, κ.ά.
Έκδοση: (2010-01-01)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
ανά: Kristen L. Bunnell PharmD, κ.ά.
Έκδοση: (2018-01-01)

Studying the Causes of Virologic Failure in the Early Stages of Antiretroviral Therapy in HIV-Infected Patients
ανά: M.H. Liulchuk
Έκδοση: (2015-02-01)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
ανά: Alexander J Szubert, κ.ά.
Έκδοση: (2017-11-01)

Correction: Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
ανά: Julie Kadima, κ.ά.
Έκδοση: (2019-01-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
ανά: V. A. Chibilyaev, κ.ά.
Έκδοση: (2015-03-01)

Effectiveness of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people with HIV with historical drug resistance mutations
ανά: Ziwei Chang, κ.ά.
Έκδοση: (2024-11-01)

HIV Drug Resistance Patterns and Characteristics Associated with Clinically Significant Drug Resistance among Children with Virologic Failure on Antiretroviral Treatment in Kenya: Findings from the Opt4Kids Randomized Controlled Trial
ανά: Lisa Abuogi, κ.ά.
Έκδοση: (2023-10-01)

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
ανά: Francis Kiweewa, κ.ά.
Έκδοση: (2019-01-01)

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.
ανά: Jallow, S, κ.ά.
Έκδοση: (2009)

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
ανά: Ingrid A. Beck, κ.ά.
Έκδοση: (2020-01-01)

Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action
ανά: Nicole A. Tillie, κ.ά.
Έκδοση: (2016-01-01)

Effect of Switching Antiretroviral Treatment Regimen in Patients With Drug-Resistant HIV-1 Infection: Retrospective Observational Cohort Study
ανά: Yiping Li, κ.ά.
Έκδοση: (2022-06-01)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
ανά: M. Ali Rai, κ.ά.
Έκδοση: (2022-09-01)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
ανά: Mulugeta Melku, κ.ά.
Έκδοση: (2020-08-01)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
ανά: Charlotte Charpentier, κ.ά.
Έκδοση: (2023-02-01)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.

Παρόμοια τεκμήρια

Παρόμοια τεκμήρια